Inflammasome
| Zeile 9: | Zeile 9: | ||
{{tp|p=32511763|t=2020. Colchicine and COVID-19.|pdf=|usr=007}} | {{tp|p=32511763|t=2020. Colchicine and COVID-19.|pdf=|usr=007}} | ||
{{tp|p=32503853|t=2020. COVID-19 infection in a patient with FMF: does colchicine have a protective effect?|pdf=|usr=007}} | {{tp|p=32503853|t=2020. COVID-19 infection in a patient with FMF: does colchicine have a protective effect?|pdf=|usr=007}} | ||
| − | + | {{tp|p=32461554|t=2020. Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.|pdf=|usr=008}} | |
topic | topic | ||
{{ttp|p=32493814|t=2020. Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.|pdf=|usr=007}} | {{ttp|p=32493814|t=2020. Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.|pdf=|usr=007}} | ||
Version vom 28. Juni 2020, 09:52 Uhr
colchicine
32337546 ä. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?
32251729 ä. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
32344275 2020. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)
32380315 2020. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
32472681 2020. Why not to use colchicine in COVID-19? An old anti-inflammatory drug for a novel auto-inflammatory disease.
32445400 2020. Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?
32511763 2020. Colchicine and COVID-19.
32503853 2020. COVID-19 infection in a patient with FMF: does colchicine have a protective effect?
32461554 2020. Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.
topic
| 32493814 2020. Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19. |
